{"id":75308,"date":"2026-09-28T20:36:27","date_gmt":"2026-09-28T20:36:27","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=75308"},"modified":"2026-09-28T20:36:27","modified_gmt":"2026-09-28T20:36:27","slug":"analyst-updates-sept-25-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/","title":{"rendered":"Analyst Updates: Sept 25, 2026"},"content":{"rendered":"

Analyst Ratings:<\/strong><\/a><\/h2>\n

Analyst sentiment for for Friday September 25th,across North American markets was selectively bullish. Technology, health care and industrials drew several positive calls, while Canadian energy also saw higher targets. Consumer, financial and real estate ratings were more mixed, with target cuts tempering the stronger recommendations. The combined outlook points to opportunities in specific sectors, but limited evidence of a broad market rally.<\/p>\n

Canadian Analyst Ratings (51 Entries)<\/h3>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

Air Canada<\/strong> (AC:CA) \u2014 Scotiabank maintained its Outperform rating with a C$37.50 target price.<\/p>\n

Alimentation Couche-Tard<\/strong> (ATD:CA) \u2014 Scotiabank maintained its Outperform rating with a C$102.00 target price.<\/p>\n

Allied Properties REIT<\/strong> (AP.UN:CA) \u2014 Scotiabank assigned a C$10.50 target price.<\/p>\n

AltaGas<\/strong> (ALA:CA) \u2014 Scotiabank maintained its Outperform rating with a C$62.00 target price.<\/p>\n

Altius Minerals<\/strong> (ALS:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$65.00 target price.<\/p>\n

Aritzia<\/strong> (ATZ:CA) \u2014 RBC Capital lowered its target price to C$191.00 from C$202.00 while maintaining its Outperform rating.<\/p>\n

Athabasca Oil<\/strong> (ATH:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$11.00 target price.<\/p>\n

Auxly Cannabis Group<\/strong> (XLY:CA) \u2014 Acumen Capital maintained its Buy rating with a C$5.00 target price.<\/p>\n

B2Gold<\/strong> (BTO:CA) \u2014 Scotiabank maintained its Outperform rating with a C$10.00 target price.<\/p>\n

Bank of Montreal<\/strong> (BMO:CA) \u2014 Scotiabank maintained its Sector Outperform rating with a C$270.00 target price.<\/p>\n

Baytex Energy<\/strong> (BTE:CA) \u2014 Scotiabank maintained its Outperform rating with a C$7.50 target price.<\/p>\n

BCE-Inc. <\/strong>(BCE:CA) \u2014 Scotiabank maintained its Outperform rating with a C$40.00 target price.<\/p>\n

Birchcliff Energy<\/strong> (BIR:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$7.75 target price.<\/p>\n

BlackBerry<\/strong> (BB:CA) \u2014 TD Securities maintained its Hold rating with a C$11.00 target price.<\/p>\n

Bombardier<\/strong> (BBD.B:CA) \u2014 RBC Capital maintained its Outperform rating with a C$406.00 target price.<\/p>\n

Bombardier<\/strong> (BBD.B:CA) \u2014 Scotiabank maintained its Outperform rating with a C$380.00 target price.<\/p>\n

Brookfield Infrastructure Partners<\/strong> (BIP-UN:CA) \u2014 TD Securities maintained its Buy rating with a C$80.00 target price.<\/p>\n

Brookfield Renewable Partners<\/strong> (BEP-UN:CA) \u2014 TD Securities maintained its Buy rating with a C$55.00 target price.<\/p>\n

Canadian Imperial Bank of Commerce<\/strong> (CM:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$174.00 target price.<\/p>\n

Canadian National Railway<\/strong> (CNR:CA) \u2014 Scotiabank maintained its Outperform rating with a C$199.00 target price.<\/p>\n

Canadian Natural Resources<\/strong> (CNQ:CA) \u2014 Desjardins Securities raised its target price to C$73.00 from C$70.00 while maintaining its Hold rating.<\/p>\n

Canadian Tire<\/strong> (CTC-A:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$200.00 target price.<\/p>\n

Cenovus Energy<\/strong> (CVE:CA) \u2014 Desjardins Securities raised its target price to C$52.00 from C$50.00 while maintaining its Buy rating.<\/p>\n

Chorus Aviation<\/strong> (CHR:CA) \u2014 RBC Capital maintained its Outperform rating with a C$39.00 target price.<\/p>\n

Enbridge<\/strong> (ENB:CA) \u2014 Scotiabank maintained its Outperform rating with a C$84.00 target price.<\/p>\n

Fairfax Financial Holdings<\/strong> (FFH:CA) \u2014 Scotiabank maintained its Outperform rating with a C$2,950.00 target price.<\/p>\n

First Mining Gold<\/strong> (FF:CA) \u2014 National Bank raised its target price to C$1.50 from C$1.30 while maintaining its Outperform rating.<\/p>\n

First Quantum Minerals<\/strong> (FM:CA) \u2014 Scotiabank maintained its Outperform rating with a C$53.00 target price.<\/p>\n

FirstService<\/strong> (FSV:CA) \u2014 TD Securities maintained its Buy rating with a C$276.00 target price.<\/p>\n

HEALWELL AI<\/strong> (AIDX:CA) \u2014 Scotiabank maintained its Outperform rating with a C$1.50 target price.<\/p>\n

Imperial Oil<\/strong> (IMO:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$156.00 target price.<\/p>\n

Imperial Oil<\/strong> (IMO:CA) \u2014 Desjardins Securities raised its target price to C$165.00 from C$160.00 while maintaining its Hold rating.<\/p>\n

Loblaw Companies<\/strong> (L:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$67.00 target price.<\/p>\n

Martinrea International<\/strong> (MRE:CA) \u2014 CIBC maintained its Outperform rating with a C$12.50 target price.<\/p>\n

Meren Energy<\/strong> (MER:CA) \u2014 Scotiabank maintained its Sector Perform rating with a C$2.50 target price.<\/p>\n

Russel Metals<\/strong> (RUS:CA) \u2014 RBC Capital maintained its Outperform rating with a C$92.00 target price.<\/p>\n

Sangoma Technologies<\/strong> (STC:CA) \u2014 TD Securities maintained its Buy rating with a C$9.00 target price.<\/p>\n

Slate Grocery REIT<\/strong> (SGR.U:CA) \u2014 CIBC lowered its target price to C$8.25 from C$12.00.<\/p>\n

Spin Master<\/strong> (TOY:CA) \u2014 CIBC maintained its Neutral rating with a C$23.00 target price.<\/p>\n

Suncor Energy<\/strong> (SU:CA) \u2014 Desjardins Securities raised its target price to C$110.00 from C$107.00 while maintaining its Buy rating.<\/p>\n

The Cronos Group<\/strong> (CRON:CA) \u2014 TD Securities raised its target price to C$7.00 from C$6.00 while maintaining its Buy rating.<\/p>\n

Total Energy Services<\/strong> (TOT:CA) \u2014 RBC Capital initiated coverage with a Sector Perform rating and a C$41.00 target price.<\/p>\n

Tourmaline Oil<\/strong> (TOU:CA) \u2014 Jefferies raised its target price to C$72.00 from C$71.00.<\/p>\n

Tourmaline Oil<\/strong> (TOU:CA) \u2014 Desjardins Securities raised its target price to C$69.00 from C$68.00 while maintaining its Hold rating.<\/p>\n

Transcontinental<\/strong> (GIB-A:CA) \u2014 CIBC maintained its Outperform rating with a C$7.00 target price.<\/p>\n

Vecima Networks<\/strong> (VCM:CA) \u2014 Acumen Capital raised its target price to C$24.00 from C$18.00 while maintaining its Buy rating.<\/p>\n

Vecima Networks<\/strong> (VCM:CA) \u2014 Raymond James raised its target price to C$19.00 from C$18.00 while maintaining its Outperform rating.<\/p>\n

Vecima Networks<\/strong> (VCM:CA) \u2014 B. Riley raised its target price to C$22.00 from C$21.00.<\/p>\n

Whitecap Resources<\/strong> (WCP:CA) \u2014 Desjardins Securities raised its target price to C$23.00 from C$22.00 while maintaining its Buy rating.<\/p>\n

WildBrain<\/strong> (WILD:CA) \u2014 ATB Cormark lowered its target price to C$1.35 from C$1.70 while maintaining its Sector Perform rating.<\/p>\n

WildBrain<\/strong> (WILD:CA) \u2014 National Bank lowered its target price to C$1.50 from C$1.75 while maintaining its Sector Perform rating.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
<\/div>\n<\/div>\n

U.S. Analyst Ratings (259 Entries)<\/h3>\n

3M (MMM)<\/strong> \u2014 Sanford C. Bernstein upgraded the stock from Underperform to Market Perform and raised its price target to $171.00 from $145.00.<\/p>\n

Abeona Therapeutics (ABEO)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Abeona Therapeutics (ABEO)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Acadian Asset Management (AAMI)<\/strong> \u2014 Morgan Stanley raised its price target to $95.00 from $81.00 and maintained an Equal Weight rating.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 Needham & Company lowered its price target to $35.00 from $41.00 and maintained a Buy rating.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 Deutsche Bank lowered its price target to $31.00 from $38.00 and maintained a Buy rating.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 HC Wainwright lowered its price target to $33.00 from $37.00 and maintained a Buy rating.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 Citizens JMP lowered its price target to $33.00 from $36.00 and maintained a Market Outperform rating.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 Citigroup reiterated its Buy rating and lowered its price target to $33.00 from $40.00.<\/p>\n

Accenture (ACN)<\/strong> \u2014 JPMorgan Chase raised its price target to $200.00 from $179.00 and maintained an Overweight rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Bank of America raised its price target to $185.00 from $175.00 and maintained a Buy rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 UBS Group raised its price target to $148.00 from $143.00 and maintained a Neutral rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Guggenheim raised its price target to $225.00 from $190.00 and maintained a Buy rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 TD Cowen raised its price target to $149.00 from $140.00 and maintained a Hold rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 JPMorgan Chase raised its price target to $167.00 from $158.00 and maintained a Neutral rating.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating and raised its price target to $158.00 from $125.00.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 DA Davidson reiterated its Buy rating with a $185.00 price target.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 RBC Capital reiterated its Sector Perform rating with a $135.00 price target.<\/p>\n

Alaska Air Group (ALK)<\/strong> \u2014 Raymond James reiterated its Outperform rating.<\/p>\n

Aligos Therapeutics (ALGS)<\/strong> \u2014 Jefferies upgraded the stock to Strong Buy.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 Citigroup lowered its price target to $50.00 from $58.00 and maintained a Buy rating.<\/p>\n

Almonty Industries (ALM)<\/strong> \u2014 Stifel initiated coverage with a Buy rating and a $25.00 price target.<\/p>\n

Alta Equipment Group (ALTG)<\/strong> \u2014 Citigroup reiterated its Outperform rating.<\/p>\n

Alta Equipment Group (ALTG)<\/strong> \u2014 Northland Securities set a $12.00 price target.<\/p>\n

AMC Entertainment (AMC)<\/strong> \u2014 Citigroup reiterated its Sell rating and raised its price target to $2.20 from $1.80.<\/p>\n

Ameren (AEE)<\/strong> \u2014 RBC Capital lowered its price target to $107.00 from $114.00 and maintained a Sector Perform rating.<\/p>\n

Andersen Group (ANDG)<\/strong> \u2014 Truist Financial raised its price target to $70.00 from $55.00 and maintained a Buy rating.<\/p>\n

Apple (AAPL)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating.<\/p>\n

Arthur J. Gallagher & Co. (AJG)<\/strong> \u2014 Morgan Stanley lowered its price target to $285.00 from $290.00 and maintained an Overweight rating.<\/p>\n

Ascendis Pharma (ASND)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating with a $300.00 price target.<\/p>\n

Assured Guaranty (AGO)<\/strong> \u2014 Roth Capital upgraded the stock from Neutral to Buy and raised its price target to $85.00 from $80.00.<\/p>\n

AxoGen (AXGN)<\/strong> \u2014 Raymond James raised its price target to $53.00 from $48.00 and maintained an Outperform rating.<\/p>\n

Axsome Therapeutics (AXSM)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Axsome Therapeutics (AXSM)<\/strong> \u2014 Morgan Stanley lowered its price target to $247.00 from $251.00 and maintained an Equal Weight rating.<\/p>\n

Bank of New York Mellon (BNY)<\/strong> \u2014 Truist Financial lowered its price target to $172.00 from $178.00 and maintained a Buy rating.<\/p>\n

Biodesix (BDSX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and raised its price target to $38.00 from $27.00.<\/p>\n

BlackBerry (BB)<\/strong> \u2014 Canaccord Genuity lowered its price target to $9.50 from $10.30 and maintained a Hold rating.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Morgan Stanley lowered its price target to $1,479.00 from $1,488.00 and maintained an Overweight rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $100.00 price target.<\/p>\n

Block (XYZ)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating with a $95.00 price target.<\/p>\n

BP (BP)<\/strong> \u2014 HSBC upgraded the stock from Hold to Buy and raised its price target to $51.30 from $46.00.<\/p>\n

Brightstar Lottery (BRSL)<\/strong> \u2014 Stifel set a $19.00 price target.<\/p>\n

Brixmor Property Group (BRX)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating.<\/p>\n

Camden Property Trust (CPT)<\/strong> \u2014 Truist Financial lowered its price target to $108.00 from $123.00 and maintained a Buy rating.<\/p>\n

Cardinal Infrastructure Group (CDNL)<\/strong> \u2014 Truist Financial initiated coverage with a Buy rating and a $40.00 price target.<\/p>\n

CarMax (KMX)<\/strong> \u2014 Stephens raised its price target to $74.00 from $66.00 and maintained an Overweight rating.<\/p>\n

CF Industries (CF)<\/strong> \u2014 Sanford C. Bernstein initiated coverage with an Outperform rating and a $162.00 price target.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 Barclays raised its price target to $330.00 from $300.00 and maintained an Overweight rating.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 TD Cowen raised its price target to $325.00 from $300.00 and maintained a Buy rating.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 RBC Capital raised its price target to $322.00 from $282.00 and maintained an Outperform rating.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 Robert W. Baird raised its price target to $334.00 from $291.00 and maintained an Outperform rating.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 Mizuho raised its price target to $295.00 from $264.00 and maintained a Neutral rating.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 Deutsche Bank raised its price target to $320.00 from $300.00 and maintained a Buy rating.<\/p>\n

Charles River Laboratories (CRL)<\/strong> \u2014 Evercore set a $330.00 price target.<\/p>\n

Charter Communications (CHTR)<\/strong> \u2014 Morgan Stanley lowered its price target to $140.00 from $150.00 and maintained an Equal Weight rating.<\/p>\n

Charter Communications (CHTR)<\/strong> \u2014 Goldman Sachs lowered its price target to $110.00 from $120.00 and maintained a Sell rating.<\/p>\n

Chemed (CHE)<\/strong> \u2014 UBS Group initiated coverage with a Buy rating and a $650.00 price target.<\/p>\n

Chevron (CVX)<\/strong> \u2014 HSBC raised its price target to $250.00 from $218.00 and maintained a Buy rating.<\/p>\n

Chevron (CVX)<\/strong> \u2014 UBS Group set a $250.00 price target.<\/p>\n

Cipher Mining (CIFR)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Cognizant Technology Solutions (CTSH)<\/strong> \u2014 Daiwa Securities raised its price target to $60.00 from $42.00 and maintained a Neutral rating.<\/p>\n

Comcast (CMCSA)<\/strong> \u2014 Morgan Stanley lowered its price target to $27.00 from $29.00 and maintained an Equal Weight rating.<\/p>\n

Comstock Resources (CRK)<\/strong> \u2014 Jefferies initiated coverage with a Hold rating and a $14.00 price target.<\/p>\n

Consensus Cloud Solutions (CCSI)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $50.00 price target.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 JPMorgan Chase lowered its price target to $133.00 from $165.00 and maintained a Neutral rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Roth Capital reiterated its Sell rating with a $781.00 price target.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 TD Cowen reiterated its Buy rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Robert W. Baird set a $1,175.00 price target.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 HSBC upgraded the stock to Buy.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Raymond James lowered its price target to $1,050.00 from $1,100.00 and maintained an Outperform rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to $1,143.00 from $1,144.00 and maintained an Outperform rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Mizuho lowered its price target to $1,065.00 from $1,100.00 and maintained an Outperform rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 RBC Capital reiterated its Sector Perform rating with a $1,000.00 price target.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Wells Fargo lowered its price target to $950.00 from $1,000.00 and maintained an Equal Weight rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 JPMorgan Chase lowered its price target to $1,015.00 from $1,100.00 and maintained an Overweight rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Truist Financial lowered its price target to $955.00 from $1,011.00 and maintained a Hold rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 DA Davidson raised its price target to $1,040.00 from $1,000.00 and maintained a Neutral rating.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 Jefferies lowered its price target to $1,100.00 from $1,130.00.<\/p>\n

Coya Therapeutics (COYA)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Cracker Barrel Old Country Store (CBRL)<\/strong> \u2014 Citigroup raised its price target to $44.00 from $42.00 and maintained a Sell rating.<\/p>\n

Cullinan Therapeutics (CGEM)<\/strong> \u2014 HC Wainwright raised its price target to $35.00 from $30.00 and maintained a Buy rating.<\/p>\n

Cullinan Therapeutics (CGEM)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $40.00 price target.<\/p>\n

Damora Therapeutics (DMRA)<\/strong> \u2014 Guggenheim raised its price target to $60.00 from $40.00 and maintained a Buy rating.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating with a $230.00 price target.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $235.00 price target.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 Stephens reiterated its Equal Weight rating with a $220.00 price target.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 BMO Capital Markets lowered its price target to $220.00 from $225.00 and maintained a Market Perform rating.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 Mizuho raised its price target to $245.00 from $235.00 and maintained an Outperform rating.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 Guggenheim reiterated its Buy rating with a $235.00 price target.<\/p>\n

Darden Restaurants (DRI)<\/strong> \u2014 Citigroup lowered its price target to $247.00 from $248.00 and maintained a Buy rating.<\/p>\n

D.R. Horton (DHI)<\/strong> \u2014 Evercore set a $166.00 price target.<\/p>\n

Eastman Chemical (EMN)<\/strong> \u2014 Jefferies reiterated its Buy rating with a $85.00 price target.<\/p>\n

Emerson Electric (EMR)<\/strong> \u2014 Wells Fargo initiated coverage with an Overweight rating and a $177.00 price target.<\/p>\n

Emerson Electric (EMR)<\/strong> \u2014 TD Cowen raised its price target to $170.00 from $150.00 and maintained a Hold rating.<\/p>\n

Everpure (P)<\/strong> \u2014 Barclays raised its price target to $132.00 from $110.00 and maintained an Equal Weight rating.<\/p>\n

Fervo Energy (FRVO)<\/strong> \u2014 Wolfe Research upgraded the stock from Peer Perform to Outperform with a $29.00 price target.<\/p>\n

Fervo Energy (FRVO)<\/strong> \u2014 Bank of America lowered its price target to $30.00 from $36.00 and maintained a Buy rating.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 Robert W. Baird lowered its price target to $45.00 from $48.00 and maintained a Neutral rating.<\/p>\n

Five Below (FIVE)<\/strong> \u2014 Goldman Sachs reiterated its Buy rating with a $306.00 price target.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 Evercore set a $45.00 price target.<\/p>\n

Franklin Resources (BEN)<\/strong> \u2014 Morgan Stanley raised its price target to $35.00 from $34.00 and maintained an Equal Weight rating.<\/p>\n

Gen Digital (GEN)<\/strong> \u2014 RBC Capital lowered its price target to $26.00 from $30.00 and maintained a Sector Perform rating.<\/p>\n

Generac (GNRC)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

General Mills (GIS)<\/strong> \u2014 Barclays raised its price target to $37.00 from $36.00 and maintained an Equal Weight rating.<\/p>\n

Genius Sports (GENI)<\/strong> \u2014 JPMorgan Chase initiated coverage with an Overweight rating and a $8.00 price target.<\/p>\n

GoDaddy (GDDY)<\/strong> \u2014 Robert W. Baird raised its price target to $120.00 from $110.00 and maintained an Outperform rating.<\/p>\n

Goldman Sachs (GS)<\/strong> \u2014 Wells Fargo lowered its price target to $1,175.00 from $1,325.00 and maintained an Overweight rating.<\/p>\n

Grab (GRAB)<\/strong> \u2014 Bank of America reiterated its Buy rating.<\/p>\n

GRAIL (GRAL)<\/strong> \u2014 Mizuho raised its price target to $100.00 from $65.00 and maintained a Neutral rating.<\/p>\n

Gulfport Energy (GPOR)<\/strong> \u2014 Jefferies downgraded the stock from Buy to Hold and lowered its price target to $180.00 from $239.00.<\/p>\n

H. B. Fuller (FUL)<\/strong> \u2014 Robert W. Baird lowered its price target to $65.00 from $75.00 and maintained an Outperform rating.<\/p>\n

Honeywell International (HON)<\/strong> \u2014 Wells Fargo initiated coverage with an Equal Weight rating and a $231.00 price target.<\/p>\n

Honeywell International (HON)<\/strong> \u2014 Rothschild & Co Redburn lowered its price target to $234.00 from $237.00 and maintained a Neutral rating.<\/p>\n

Humana (HUM)<\/strong> \u2014 Barclays upgraded the stock from Equal Weight to Overweight and raised its price target to $515.00 from $407.00.<\/p>\n

Infleqtion (INFQ)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $25.00 price target.<\/p>\n

Installed Building Products (IBP)<\/strong> \u2014 Evercore set a $222.00 price target.<\/p>\n

Invesco (IVZ)<\/strong> \u2014 Morgan Stanley raised its price target to $31.00 from $30.00 and maintained an Equal Weight rating.<\/p>\n

Ironwood Pharmaceuticals (IRWD)<\/strong> \u2014 Jefferies upgraded the stock to Hold.<\/p>\n

JPMorgan Chase (JPM)<\/strong> \u2014 Jefferies reiterated its Neutral rating.<\/p>\n

Kimberly-Clark (KMB)<\/strong> \u2014 Bank of America lowered its price target to $120.00 from $122.00 and maintained a Buy rating.<\/p>\n

Kinross Gold (KGC)<\/strong> \u2014 CIBC lowered its price target to $50.00 from $54.00 and maintained an Outperformer rating.<\/p>\n

Knife River (KNF)<\/strong> \u2014 B. Riley lowered its price target to $65.00 from $105.00 and maintained a Buy rating.<\/p>\n

Kodiak AI (KDK)<\/strong> \u2014 Chardan Capital reiterated its Buy rating with a $12.00 price target.<\/p>\n

Kopin (KOPN)<\/strong> \u2014 Stifel set a $6.50 price target.<\/p>\n

Kyverna Therapeutics (KYTX)<\/strong> \u2014 Benchmark reiterated its Buy rating.<\/p>\n

Kyverna Therapeutics (KYTX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Kyverna Therapeutics (KYTX)<\/strong> \u2014 Needham & Company set a $25.00 price target.<\/p>\n

L3Harris Technologies (LHX)<\/strong> \u2014 Argus downgraded the stock from Buy to Hold.<\/p>\n

Lennox International (LII)<\/strong> \u2014 Wells Fargo initiated coverage with an Equal Weight rating and a $424.00 price target.<\/p>\n

Ligand Pharmaceuticals (LGND)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating and a $345.00 price target.<\/p>\n

Lionsgate Studios (LION)<\/strong> \u2014 JPMorgan Chase initiated coverage with an Underweight rating and a $9.00 price target.<\/p>\n

LyondellBasell Industries (LYB)<\/strong> \u2014 UBS Group lowered its price target to $62.00 from $64.00 and maintained a Neutral rating.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 HC Wainwright set a $250.00 price target.<\/p>\n

Medline (MDLN)<\/strong> \u2014 UBS Group lowered its price target to $43.00 from $45.00 and maintained a Buy rating.<\/p>\n

Meritage Homes (MTH)<\/strong> \u2014 Evercore set a $65.00 price target.<\/p>\n

Merlin (MRLN)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and a $7.50 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Deutsche Bank raised its price target to $820.00 from $750.00 and maintained a Buy rating.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 TD Cowen raised its price target to $865.00 from $750.00 and maintained a Buy rating.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Canaccord Genuity raised its price target to $950.00 from $930.00 and maintained a Buy rating.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Piper Sandler raised its price target to $875.00 from $785.00 and maintained an Overweight rating.<\/p>\n

Moderna (MRNA)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating.<\/p>\n

Mohawk Industries (MHK)<\/strong> \u2014 Evercore set a $129.00 price target.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 Wells Fargo lowered its price target to $223.00 from $240.00 and maintained an Equal Weight rating.<\/p>\n

Natera (NTRA)<\/strong> \u2014 RBC Capital raised its price target to $460.00 from $350.00 and maintained an Outperform rating.<\/p>\n

Nektar Therapeutics (NKTR)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $178.00 price target.<\/p>\n

Nike (NKE)<\/strong> \u2014 Goldman Sachs lowered its price target to $38.00 from $42.00 and maintained a Neutral rating.<\/p>\n

Nike (NKE)<\/strong> \u2014 Bank of America downgraded the stock from Neutral to Underperform and lowered its price target to $30.00 from $47.00.<\/p>\n

Oklo (OKLO)<\/strong> \u2014 UBS Group reiterated its Neutral rating and lowered its price target to $41.00 from $55.00.<\/p>\n

Okta (OKTA)<\/strong> \u2014 Stephens raised its price target to $240.00 from $190.00 and maintained an Overweight rating.<\/p>\n

Okta (OKTA)<\/strong> \u2014 Robert W. Baird raised its price target to $235.00 from $200.00 and maintained an Outperform rating.<\/p>\n

Okta (OKTA)<\/strong> \u2014 BMO Capital Markets raised its price target to $230.00 from $187.00 and maintained an Outperform rating.<\/p>\n

Park National (PRK)<\/strong> \u2014 Hovde Group initiated coverage with a Market Perform rating and a $190.00 price target.<\/p>\n

Park National (PRK)<\/strong> \u2014 National Bank Financial set a $190.00 price target.<\/p>\n

Park National (PRK)<\/strong> \u2014 Piper Sandler reiterated its Neutral rating.<\/p>\n

Paychex (PAYX)<\/strong> \u2014 TD Cowen lowered its price target to $105.00 from $117.00 and maintained a Hold rating.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 Deutsche Bank reiterated its Hold rating with a $55.00 price target.<\/p>\n

PDF Solutions (PDFS)<\/strong> \u2014 Needham & Company initiated coverage with a Buy rating and a $60.00 price target.<\/p>\n

PetMed Express (PETS)<\/strong> \u2014 Morgan Stanley lowered its price target to $1.40 from $2.15 and maintained an Underweight rating.<\/p>\n

Planet Fitness (PLNT)<\/strong> \u2014 UBS Group reiterated its Overweight rating.<\/p>\n

Porch Group (PRCH)<\/strong> \u2014 Cantor Fitzgerald raised its price target to $20.00 from $18.00 and maintained an Overweight rating.<\/p>\n

Precigen (PGEN)<\/strong> \u2014 B. Riley initiated coverage with a Buy rating and a $12.00 price target.<\/p>\n

Prime Medicine (PRME)<\/strong> \u2014 Chardan Capital reiterated its Buy rating with a $7.00 price target.<\/p>\n

Prime Medicine (PRME)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Progress Software (PRGS)<\/strong> \u2014 Jefferies upgraded the stock to Hold.<\/p>\n

PulteGroup (PHM)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

Pursuit Attractions and Hospitality (PRSU)<\/strong> \u2014 Citigroup initiated coverage with an Outperform rating.<\/p>\n

Pursuit Attractions and Hospitality (PRSU)<\/strong> \u2014 Citizens JMP initiated coverage with a Market Outperform rating and a $64.00 price target.<\/p>\n

Restaurant Brands International (QSR)<\/strong> \u2014 Argus downgraded the stock from Buy to Hold.<\/p>\n

Rezolute (RZLT)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Rezolute (RZLT)<\/strong> \u2014 HSBC upgraded the stock to Buy.<\/p>\n

Rezolute (RZLT)<\/strong> \u2014 HC Wainwright raised its price target to $10.00 from $5.00 and maintained a Buy rating.<\/p>\n

Seaport Therapeutics (SPTX)<\/strong> \u2014 Raymond James initiated coverage with a Strong Buy rating and a $46.00 price target.<\/p>\n

ServiceTitan (TTAN)<\/strong> \u2014 TD Cowen reiterated its Buy rating with a $100.00 price target.<\/p>\n

Sherwin-Williams (SHW)<\/strong> \u2014 Wells Fargo lowered its price target to $340.00 from $360.00 and maintained an Equal Weight rating.<\/p>\n

Solaris Energy Infrastructure (SEI)<\/strong> \u2014 Wells Fargo reiterated its Outperform rating with a $85.00 price target.<\/p>\n

Southern (SO)<\/strong> \u2014 Citigroup lowered its price target to $104.00 from $114.00 and maintained a Buy rating.<\/p>\n

Sprouts Farmers Market (SFM)<\/strong> \u2014 Deutsche Bank lowered its price target to $77.00 from $84.00 and maintained a Hold rating.<\/p>\n

Stem (STEM)<\/strong> \u2014 UBS Group upgraded the stock from Neutral to Buy with a $7.00 price target.<\/p>\n

Summit Therapeutics (SMMT)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Surrozen (SRZN)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and raised its price target to $54.00 from $44.00.<\/p>\n

Target (TGT)<\/strong> \u2014 Goldman Sachs reiterated its Neutral rating.<\/p>\n

TD SYNNEX (SNX)<\/strong> \u2014 Morgan Stanley raised its price target to $359.00 from $334.00 and maintained an Overweight rating.<\/p>\n

TD SYNNEX (SNX)<\/strong> \u2014 UBS Group raised its price target to $379.00 from $352.00 and maintained a Buy rating.<\/p>\n

TELA Bio (TELA)<\/strong> \u2014 UBS Group set a $2.00 price target.<\/p>\n

TELA Bio (TELA)<\/strong> \u2014 Craig Hallum initiated coverage with a Buy rating and a $2.00 price target.<\/p>\n

Telix Pharmaceuticals (TLX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating with a $20.00 price target.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 RBC Capital reiterated its Buy rating.<\/p>\n

Texas Roadhouse (TXRH)<\/strong> \u2014 Evercore set a $220.00 price target.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Deutsche Bank reiterated its Buy rating with a $720.00 price target.<\/p>\n

T-Mobile US (TMUS)<\/strong> \u2014 Goldman Sachs lowered its price target to $211.00 from $230.00 and maintained a Buy rating.<\/p>\n

Toll Brothers (TOL)<\/strong> \u2014 Evercore set a $184.00 price target.<\/p>\n

TotalEnergies (TTE)<\/strong> \u2014 HSBC upgraded the stock from Hold to Buy.<\/p>\n

Tower Semiconductor (TSEM)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a $300.00 price target.<\/p>\n

Trane Technologies (TT)<\/strong> \u2014 Wells Fargo initiated coverage with an Overweight rating and a $536.00 price target.<\/p>\n

Trevi Therapeutics (TRVI)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Triumph Financial (TFIN)<\/strong> \u2014 Raymond James lowered its price target to $84.00 from $89.00 and maintained an Outperform rating.<\/p>\n

T. Rowe Price (TROW)<\/strong> \u2014 Morgan Stanley lowered its price target to $110.00 from $116.00 and maintained an Equal Weight rating.<\/p>\n

UiPath (PATH)<\/strong> \u2014 UBS Group lowered its price target to $14.00 from $19.00 and maintained a Neutral rating.<\/p>\n

Vaxcyte (PCVX)<\/strong> \u2014 Needham & Company reiterated its Buy rating with a $110.00 price target.<\/p>\n

Victory Capital (VCTR)<\/strong> \u2014 Morgan Stanley raised its price target to $115.00 from $91.00 and maintained an Equal Weight rating.<\/p>\n

Virtus Investment Partners (VRTS)<\/strong> \u2014 Morgan Stanley lowered its price target to $120.00 from $130.00 and maintained an Underweight rating.<\/p>\n

Wealthfront (WLTH)<\/strong> \u2014 Needham & Company initiated coverage with a Buy rating and a $13.00 price target.<\/p>\n

Welltower (WELL)<\/strong> \u2014 Jefferies upgraded the stock to Strong Buy.<\/p>\n

Western Union (WU)<\/strong> \u2014 Monness Crespi & Hardt lowered its price target to $5.00 from $6.00 and maintained a Sell rating.<\/p>\n

Westlake (WLK)<\/strong> \u2014 UBS Group lowered its price target to $98.00 from $106.00 and maintained a Buy rating.<\/p>\n

WisdomTree (WT)<\/strong> \u2014 Morgan Stanley raised its price target to $27.00 from $21.00 and maintained an Equal Weight rating.<\/p>\n

W.P. Carey (WPC)<\/strong> \u2014 Citigroup reported a change in its rating from Hold to Market Perform.<\/p>\n

W.W. Grainger (GWW)<\/strong> \u2014 Barclays lowered its price target to $1,172.00 from $1,185.00 and maintained an Underweight rating.<\/p>\n

Zscaler (ZS)<\/strong> \u2014 RBC Capital raised its price target to $236.00 from $210.00 and maintained an Outperform rating.<\/p>\n

Zscaler (ZS)<\/strong> \u2014 Mizuho raised its price target to $220.00 from $210.00 and maintained an Outperform rating.<\/p>\n

Zscaler (ZS)<\/strong> \u2014 Guggenheim reiterated its Buy rating.<\/p>\n

More Ratings:<\/em><\/strong><\/a><\/h3>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings: Analyst sentiment for for Friday September 25th,across North American markets was selectively bullish. Technology, health care and industrials drew several positive calls,…<\/p>\n","protected":false},"author":3,"featured_media":75312,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-75308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAnalyst Updates: Sept 25, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analyst Updates: Sept 25, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings: Analyst sentiment for for Friday September 25th,across North American markets was selectively bullish. Technology, health care and industrials drew several positive calls,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-28T20:36:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/09\/ChatGPT-Image-Sep-28-2026-04_18_36-PM-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"18 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Analyst Updates: Sept 25, 2026\",\"datePublished\":\"2026-09-28T20:36:27+00:00\",\"dateModified\":\"2026-09-28T20:36:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\"},\"wordCount\":3837,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\",\"name\":\"Analyst Updates: Sept 25, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-09-28T20:36:27+00:00\",\"dateModified\":\"2026-09-28T20:36:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analyst Updates: Sept 25, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analyst Updates: Sept 25, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/","og_locale":"en_US","og_type":"article","og_title":"Analyst Updates: Sept 25, 2026","og_description":"Analyst Ratings: Analyst sentiment for for Friday September 25th,across North American markets was selectively bullish. Technology, health care and industrials drew several positive calls,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-09-28T20:36:27+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/09\/ChatGPT-Image-Sep-28-2026-04_18_36-PM-1.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"18 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Analyst Updates: Sept 25, 2026","datePublished":"2026-09-28T20:36:27+00:00","dateModified":"2026-09-28T20:36:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/"},"wordCount":3837,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/","name":"Analyst Updates: Sept 25, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-09-28T20:36:27+00:00","dateModified":"2026-09-28T20:36:27+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-25-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Analyst Updates: Sept 25, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=75308"}],"version-history":[{"count":6,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75308\/revisions"}],"predecessor-version":[{"id":75317,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75308\/revisions\/75317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/75312"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=75308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=75308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=75308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}